Theme Leader, New Marketplace
Member of the NEJM Catalyst Leadership Board

Leemore Dafny, PhD

Bruce V. Rauner Professor of Business Administration
Harvard Business School

Leemore Dafny is the Bruce V. Rauner Professor of Business Administration at the Harvard Business School. Prior to joining the Harvard faculty in 2016, she served as Director of Health Enterprise Management and Professor of Strategy at the Kellogg School of Management at Northwestern University. Her research examines competitive interactions among payers and providers of healthcare services, and the intersection of industry and public policy. Dafny’s work has been published in academic journals such as the American Economic Review and The New England Journal of Medicine, and featured in popular media such as The New York Times and The Wall Street Journal.

Current projects include studies of consolidation in the U.S. hospital industry and the kidney dialysis industry, products and pricing on the public health insurance exchanges, copayment coupons for prescription drugs, and the implications of for-profit ownership of insurance companies.

Dafny graduated summa cum laude from Harvard College and worked as a consultant with McKinsey & Company prior to earning her PhD in economics from the Massachusetts Institute of Technology. She has won several teaching awards as well as Kellogg’s leading research prize, the Stanley Reiter Best Paper award. Dafny is a Research Associate of the National Bureau of Economic Research, Editor of The International Journal of Health Economics and Management, and a Board Member of the American Society of Health Economists and the Health Care Cost Institute.

Dafny’s expertise spans both the public and private sectors. She currently serves on the Panel of Health Advisers for the Congressional Budget Office. In 2012–2013, she was Deputy Director for Healthcare and Antitrust in the Bureau of Economics at the Federal Trade Commission in Washington, DC. Dafny advises companies, government agencies, and nonprofits on a variety of issues including antitrust matters, strategic decisions, and public policy.

Shift Toward Value-Based Payments in the Industry and at Organizations Is Accelerating

New Marketplace

New Marketplace Survey: What’s Next for Payment Reform?

As health care reform struggles to gain traction legislatively, health care professionals report that payment reforms continue to move forward at a moderate pace, and indeed are essential to achieving the Triple Aim.

Leemore Dafny Profit Cycle Talk Still: Rules of Business = Rules of Health Care

New Marketplace

Rules of Business = Rules of Health Care

The same rules of business apply for health care when it comes to new market opportunity.

Jeffrey Kosowsky and Rushika Fernandopulle Panel Clip Still: Has the ACA Discouraged Healthcare Innovation?

New Marketplace

Has the ACA Discouraged Innovation?

Should government be involved in health care innovation?

Leadership I

Reading List: Leemore Dafny and Stephen Swensen

NEJM Catalyst New Marketplace Theme Leader Leemore Dafny and Leadership Theme Leader Stephen Swensen weigh in on the most influential and inspiring readings of their careers.

New Marketplace

Good Riddance to Big Insurance Mergers

If there is any silver lining, it’s that other insurers might learn from blocked mergers and devote more energy to growing by offering superior value, rather than by swallowing rivals.

Panel Clip Still: Why Health Care and Health Care Services Aren't Like Staples or Starbucks

New Marketplace

Why Health Care Isn’t Staples or Starbucks

Health care is local, for better or for worse.

New Marketplace

New Marketplace Survey: The Sources of Health Care Innovation

Start-ups from outside health care are the most likely source of much-needed innovation, say NEJM Catalyst Insights Council members.

New Marketplace

Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry

Although it’s not yet clear how providers will respond to value-based payment models, an examination of pharmaceutical industry practices can provide insights into problems that may arise — and practices to avoid.

Fernandopulle, Dafny & Kosowsky Panel Clip Still: New Health Care Entrants: Friends or Foes?

New Marketplace

New Entrants: Friends or Foes?

New entrants to health care typically don’t see themselves as competitors to incumbents — but the incumbents do.

Kosowsky03 Panel Clip Still: How Can Health Care Innovators Stay Ahead of Imitation?

New Marketplace

Innovation vs. Imitation: Staying Ahead of the Game

When a newbie comes in that hasn’t had to fight the fight, how do you get your customers to stay with you?

Load More
Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now